Search for: "IPR Pharmaceuticals, Inc."
Results 1 - 20
of 182
Sorted by Relevance
|
Sort by Date
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
5 May 2020, 9:37 pm
Cir. 2020)") in Pfizer Inc. v. [read post]
12 Apr 2018, 10:15 pm
Today, in Luitpold Pharmaceuticals, Inc. v. [read post]
14 Jan 2024, 9:29 pm
Mylan Pharmaceuticals Inc. [read post]
8 Oct 2019, 9:59 pm
Apotex Inc. [read post]
27 Jul 2016, 9:18 pm
Biomarin Pharmaceutical, Inc. [read post]
27 Nov 2023, 9:10 pm
Related StoriesAzurity Pharmaceuticals Inc. v. [read post]
5 Oct 2022, 8:12 pm
Patent No. 7,326,708 were either anticipated or rendered obvious by the asserted prior art, in Mylan Pharmaceuticals Inc. v. [read post]
4 Dec 2019, 9:15 am
Earlier this month, Mallinckrodt succeeded in its inter partes review (IPR) challenge against patent owner Biovie, Inc. [read post]
25 Sep 2017, 3:59 am
Allergan Inc.: Tribe-Motion-to-Dismiss-IPRs [read post]
15 Apr 2019, 9:23 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc.... [read post]
7 Jan 2024, 9:59 pm
Noonan -- One of the many changes introduced into U.S. patent law by the Leahy-Smith America Invents Act were provisions for post-grant review (PGR) and inter partes review (IPR). [read post]
29 Jul 2015, 10:00 pm
LLC and Regeneron Pharmaceuticals, Inc. filed a petition for Inter Partes Review (IPR) of the “Cabilly II” patent, U.S. [read post]
14 Nov 2010, 8:48 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-01969; filed November 11, 2010 in the District Court of Nevada • Plaintiffs: Astrazeneca UK Ltd.; IPR Pharmaceuticals, Inc.; Shionogi Seiyaku Kabushiki Kaisha • Defendants: Watson Pharmaceuticals, Inc.; Watson Pharma, Inc.; Watson Laboratories, Inc. [read post]
15 Aug 2014, 7:08 am
" Endo Pharmaceuticals, Inc. et al v. [read post]
22 Oct 2019, 9:15 am
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
27 Jun 2010, 9:11 pm
USA 1:10-cv-00543; filed June 21, 2010 in the District Court of Delaware • Plaintiffs: AstraZeneca Pharmaceuticals LP; AstraZeneca UK Ltd.; IPR Pharmaceuticals Inc.; Shionogi Seiyaku Kabushiki Kaisha • Defendant: Glenmark Generics Inc. [read post]
21 Aug 2018, 9:58 pm
Mylan Pharmaceuticals Inc., affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
9 Sep 2016, 4:15 am
The IPRs, which were filed by American pharmaceutical developer Mylan Inc. [read post]
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
